Industry News
Biotechnology Industry News
New GlaxoSmithKline keeping old R&D model, says embattled CEO
New GlaxoSmithKline keeping old R&D model, says embattled CEO badams Thu, 07/29/2021 - 07:18
AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis, as asthma focus sharpens
AstraZeneca drops Dupixent rival tezepelumab in atopic dermatitis, as asthma focus sharpens ntaylor Thu, 07/29/2021 - 06:21
Sanofi culls early infectious disease, blood disorder asset as it ramps up phase 3 for also-ran COVID vax
Sanofi culls early infectious disease, blood disorder asset as it ramps up phase 3 for also-ran COVID vax badams Thu, 07/29/2021 - 04:28
Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics
Ipsen pens early-stage, $14.5M programmed cell death cancer deal with BAKX Therapeutics badams Wed, 07/28/2021 - 09:00
GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer
GSK culls phase 2 RSV vaccine in kids, as feladilimab flops again in lung cancer ntaylor Wed, 07/28/2021 - 08:54
Pfizer dumps mid-phase NASH prospect, slew of early efforts in Q2 clear-out
Pfizer dumps mid-phase NASH prospect, slew of early efforts in Q2 clear-out ntaylor Wed, 07/28/2021 - 08:03
Novartis fine-tunes gene therapy candidates with a drug that acts as a ‘dimmer switch’
Novartis fine-tunes gene therapy candidates with a drug that acts as a 'dimmer switch' aliu Wed, 07/28/2021 - 07:59
Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B
Gilead-partnered Teneobio and its next-gen cancer work snapped up by Amgen for $2.5B badams Wed, 07/28/2021 - 04:30
Fruit compound reverses brain damage in mouse models of Parkinson’s
Fruit compound reverses brain damage in mouse models of Parkinson's klahucik Tue, 07/27/2021 - 15:47
AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push
AbbVie hits go on $1B re-upped Calico deal as the Google life science spin-out continues I-O, neuro push badams Tue, 07/27/2021 - 09:10
AbbVie hits go on $1B re-upped Calico deal as the Google life science spinout continues I-O, neuro push
AbbVie hits go on $1B re-upped Calico deal as the Google life science spinout continues I-O, neuro push badams Tue, 07/27/2021 - 09:10
Merck women’s health spinout Organon bags preterm labor drug ahead of phase 3
Merck women's health spinout Organon bags preterm labor drug ahead of phase 3 ntaylor Tue, 07/27/2021 - 08:19
Artios raises $153M to fund DNA damage repair clinical trials
Artios raises $153M to fund DNA damage repair clinical trials ntaylor Tue, 07/27/2021 - 07:43
AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics
AstraZeneca teams up with Regeneron for obesity-busting drug pact focused on genetics badams Tue, 07/27/2021 - 07:36
Prothena rolls out preclinical data for anti-amyloid Alzheimer’s candidate to rival Biogen’s Aduhelm
Prothena rolls out preclinical data for anti-amyloid Alzheimer's candidate to rival Biogen's Aduhelm klahucik Mon, 07/26/2021 - 13:21
AbbVie posts new data on drug that could replace glasses or contacts for age-related far-sightedness
AbbVie posts new data on drug that could replace glasses or contacts for age-related far-sightedness ntaylor Mon, 07/26/2021 - 08:30
Bayer poaches Ruettinger from Roche to head up early cancer R&D
Bayer poaches Ruettinger from Roche to head up early cancer R&D ntaylor Mon, 07/26/2021 - 06:05
Novel degrader of cancer-driving protein AKT slows prostate, breast tumors in mice
Novel degrader of cancer-driving protein AKT slows prostate, breast tumors in mice arlene.weintraub Fri, 07/23/2021 - 09:08
UPDATE: Half of Adverum pipeline ‘snaps out of existence’ as adverse events force pivot to more common eye disease
UPDATE: Half of Adverum pipeline 'snaps out of existence' as adverse events force pivot to more common eye disease ntaylor Fri, 07/23/2021 - 05:37
Lumos delays key hormone deficiency readout as COVID bites
Lumos delays key hormone deficiency readout as COVID bites ntaylor Fri, 07/23/2021 - 04:49